Bradykinin restores left ventricular function, sarcomeric protein phosphorylation, and e/nNOS levels in dogs with Duchenne muscular dystrophy cardiomyopathy.
暂无分享,去创建一个
L. Hittinger | J. Thibaud | I. Barthélémy | S. Blot | A. Lacampagne | Y. Ait mou | B. Ghaleh | A. Bizé | A. Berdeaux | V. Chetboul | J. Pouchelon | C. C. Sampedrano | V. Gouni | L. Sambin | O. Cazorla | H. Dabire | N. Blanchard-Gutton | J. Su | Y. Unterfinger | Pablo Aguilar | Lucien Sambin
[1] B. Liu,et al. A novel pathway of NADPH oxidase/vascular peroxidase 1 in mediating oxidative injury following ischemia–reperfusion , 2012, Basic Research in Cardiology.
[2] C. Schalkwijk,et al. Original Contribution , 1988 .
[3] Ying Ge,et al. Top-down quantitative proteomics identified phosphorylation of cardiac troponin I as a candidate biomarker for chronic heart failure. , 2011, Journal of proteome research.
[4] P. D. de Tombe,et al. Beneficial effects of SR33805 in failing myocardium. , 2011, Cardiovascular research.
[5] Alain Lacampagne,et al. Regional variation in myofilament length-dependent activation , 2011, Pflügers Archiv - European Journal of Physiology.
[6] J. Kornegay,et al. Chronic administration of membrane sealant prevents severe cardiac injury and ventricular dilatation in dystrophic dogs. , 2010, The Journal of clinical investigation.
[7] R. Moss,et al. Differential roles of regulatory light chain and myosin binding protein‐C phosphorylations in the modulation of cardiac force development , 2010, The Journal of physiology.
[8] Katherine A. Sheehan,et al. Novel bradykinin signaling in adult rat cardiac myocytes through activation of p21-activated kinase , 2010, American journal of physiology. Heart and circulatory physiology.
[9] Douglas L. Jones,et al. Neuronal Nitric Oxide Synthase Protects Against Myocardial Infarction–Induced Ventricular Arrhythmia and Mortality in Mice , 2009, Circulation.
[10] A. Shah,et al. Effects of Neuronal Nitric Oxide Synthase on Human Coronary Artery Diameter and Blood Flow In Vivo , 2009, Circulation.
[11] A. Lacampagne,et al. Late exercise training improves non-uniformity of transmural myocardial function in rats with ischaemic heart failure. , 2009, Cardiovascular research.
[12] P. Powers,et al. Acceleration of Crossbridge Kinetics by Protein Kinase A Phosphorylation of Cardiac Myosin Binding Protein C Modulates Cardiac Function , 2008, Circulation research.
[13] S. Nattel,et al. Decreased phosphorylation levels of cardiac myosin-binding protein-C in human and experimental heart failure. , 2007, Journal of molecular and cellular cardiology.
[14] Giulio Cossu,et al. Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs , 2006, Nature.
[15] A. Drousiotou,et al. Naturally occurring utrophin correlates with disease severity in Duchenne muscular dystrophy. , 2006, Human molecular genetics.
[16] J. Bronzwaer,et al. Functional effects of protein kinase C-mediated myofilament phosphorylation in human myocardium. , 2006, Cardiovascular research.
[17] J. Tidball,et al. Cardiomyopathy in dystrophin-deficient hearts is prevented by expression of a neuronal nitric oxide synthase transgene in the myocardium. , 2005, Human molecular genetics.
[18] Ajay M Shah,et al. Regulation of cardiac contractile function by troponin I phosphorylation. , 2005, Cardiovascular research.
[19] G. Vassort,et al. Transmural stretch‐dependent regulation of contractile properties in rat heart and its alteration after myocardial infarction , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[20] D. Duncker,et al. Alterations in Myofilament Function Contribute to Left Ventricular Dysfunction in Pigs Early After Myocardial Infarction , 2004, Circulation research.
[21] F. Lallemand,et al. Tissue Doppler imaging detects early asymptomatic myocardial abnormalities in a dog model of Duchenne's cardiomyopathy. , 2004, European heart journal.
[22] J. Thibaud,et al. Tissue Doppler assessment of diastolic and systolic alterations of radial and longitudinal left ventricular motions in Golden Retrievers during the preclinical phase of cardiomyopathy associated with muscular dystrophy. , 2004, American journal of veterinary research.
[23] A. Shah,et al. Increased neuronal nitric oxide synthase-derived NO production in the failing human heart , 2004, The Lancet.
[24] L. Hittinger,et al. Chronic Infusion of Bradykinin Delays the Progression of Heart Failure and Preserves Vascular Endothelium-Mediated Vasodilation in Conscious Dogs , 2003, Circulation.
[25] R. Shannon,et al. Angiotensin-Converting Enzyme Inhibitors Improve Coronary Flow Reserve in Dilated Cardiomyopathy by a Bradykinin-Mediated, Nitric Oxide-Dependent Mechanism , 2002, Circulation.
[26] J. Balligand,et al. Endogenous nitric oxide mechanisms mediate the stretch dependence of Ca2+ release in cardiomyocytes , 2001, Nature Cell Biology.
[27] R. Busse,et al. Phosphorylation of Thr495 Regulates Ca2+/Calmodulin-Dependent Endothelial Nitric Oxide Synthase Activity , 2001 .
[28] B. Kemp,et al. Reciprocal Phosphorylation and Regulation of Endothelial Nitric-oxide Synthase in Response to Bradykinin Stimulation* , 2001, The Journal of Biological Chemistry.
[29] J. Trochu,et al. Role of Endothelium-Derived Nitric Oxide in the Regulation of Cardiac Oxygen Metabolism: Implications in Health and Disease , 2000, Circulation research.
[30] G. D. Thomas,et al. Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[31] W. T. Bartlett,et al. In vivo targeted repair of a point mutation in the canine dystrophin gene by a chimeric RNA/DNA oligonucleotide , 2000, Nature Biotechnology.
[32] F. Barbe,et al. Stimulation of Bradykinin B1 Receptors Induces Vasodilation in Conductance and Resistance Coronary Vessels in Conscious Dogs Comparison With B2 Receptor Stimulation , 2000 .
[33] A. Cribier,et al. Assessment of nonuniformity of transmural myocardial velocities by color-coded tissue Doppler imaging: characterization of normal, ischemic, and stunned myocardium. , 2000, Circulation.
[34] D. Uttenweiler,et al. Myosin binding protein C, a phosphorylation-dependent force regulator in muscle that controls the attachment of myosin heads by its interaction with myosin S2. , 2000, Circulation research.
[35] T Centner,et al. Differential expression of cardiac titin isoforms and modulation of cellular stiffness. , 2000, Circulation research.
[36] G. Radda,et al. Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of Duchenne muscular dystrophy. , 1999, Journal of molecular and cellular cardiology.
[37] J. Bronzwaer,et al. Endomyocardial nitric oxide synthase and left ventricular preload reserve in dilated cardiomyopathy. , 1999, Circulation.
[38] F. Barbe,et al. Preserved vasodilator effect of bradykinin in dogs with heart failure. , 1998, Circulation.
[39] P. Huang,et al. Impaired metabolic modulation of alpha-adrenergic vasoconstriction in dystrophin-deficient skeletal muscle. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[40] N. Ohte,et al. Functional effects of endogenous bradykinin in congestive heart failure. , 1998, Journal of the American College of Cardiology.
[41] G. Dorn,et al. Effects of total replacement of atrial myosin light chain-2 with the ventricular isoform in atrial myocytes of transgenic mice. , 1998, Circulation.
[42] B. Prendergast,et al. Basal release of nitric oxide augments the Frank-Starling response in the isolated heart. , 1997, Circulation.
[43] J. Ménard,et al. Bradykinin pathway is involved in acute hemodynamic effects of enalaprilat in dogs with heart failure. , 1996, The American journal of physiology.
[44] C. Jones,et al. Role of nitric oxide in the coronary microvascular responses to adenosine and increased metabolic demand. , 1995, Circulation.
[45] H. Bécane,et al. Prevalence of left ventricular systolic dysfunction in Duchenne muscular dystrophy: an echocardiographic study. , 1994, American heart journal.
[46] R. Venema,et al. Role of protein kinase C in the phosphorylation of cardiac myosin light chain 2. , 1993, The Biochemical journal.
[47] J. Ervasti,et al. Association of dystrophin-related protein with dystrophin-associated proteins in mdx mouse muscle , 1992, Nature.
[48] R. Myerburg,et al. Differences in transient outward currents of feline endocardial and epicardial myocytes. , 1990, Circulation research.
[49] L. Politano,et al. The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy. , 1990, International journal of cardiology.
[50] Eric P. Hoffman,et al. The homologue of the Duchenne locus is defective in X-linked muscular dystrophy of dogs , 1988, Nature.
[51] K. Hizawa,et al. Life spans of Duchenne muscular dystrophy patients in the hospital care program in Japan , 1987, Journal of the Neurological Sciences.
[52] A. DeMaria,et al. Recommendations Regarding Quantitation in M-Mode Echocardiography: Results of a Survey of Echocardiographic Measurements , 1978, Circulation.
[53] J A Neubauer,et al. Quantitative Determination of Regional Oxygen Consumption in the Dog Heart , 1978, Circulation research.
[54] L. Hittinger,et al. Vascular endothelial dysfunction in Duchenne muscular dystrophy is restored by bradykinin through upregulation of eNOS and nNOS , 2011, Basic Research in Cardiology.
[55] J. Su. Kinins and cardiovascular diseases. , 2006, Current pharmaceutical design.
[56] Joao A. C. Lima,et al. Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms , 2002, Nature.
[57] K. Jan,et al. Distribution of myocardial stress and its influence on coronary blood flow. , 1985, Journal of biomechanics.
[58] E. Feigl,et al. Coronary physiology. , 1983, Physiological reviews.